Fidelity Disruptive Medicine ETF (FMED) Short Interest Ratio & Short Volume $25.54 -0.28 (-1.08%) (As of 09/6/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrends Fidelity Disruptive Medicine ETF Short Interest DataFidelity Disruptive Medicine ETF (FMED) has a short interest of 7,600 shares. This marks a -33.33% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.3, indicating that it would take 1.3 days of the average trading volume of 5,664 shares to cover all short positions.Current Short Interest7,600 sharesPrevious Short Interest11,400 sharesChange Vs. Previous Month-33.33%Dollar Volume Sold Short$192,143.20Short Interest Ratio1.3 Days to CoverLast Record DateAugust 15, 2024Outstanding Shares2,120,000 sharesPercentage of Shares Shorted0.36%Today's Trading Volume5,124 sharesAverage Trading Volume5,664 sharesToday's Volume Vs. Average90% Short Selling Fidelity Disruptive Medicine ETF? Sign up to receive the latest short interest report for Fidelity Disruptive Medicine ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartFMED Short Interest Over TimeFMED Days to Cover Over TimeFMED Percentage of Float Shorted Over Time Ad Golden CrestBiden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.>> Get Your FREE Wealth Protection Guide << Fidelity Disruptive Medicine ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/20247,600 shares $192,143.20 -33.3%N/A1.3 $25.28 7/31/202411,400 shares $281,580.00 +123.5%N/A1.9 $24.70 7/15/20245,100 shares $126,327.00 No ChangeN/A0.8 $24.77 FMED Short Interest - Frequently Asked Questions What is Fidelity Disruptive Medicine ETF's current short interest? Short interest is the volume of Fidelity Disruptive Medicine ETF shares that have been sold short but have not yet been covered or closed out. As of August 15th, investors have sold 7,600 shares of FMED short. Learn More on Fidelity Disruptive Medicine ETF's current short interest. What is a good short interest ratio for Fidelity Disruptive Medicine ETF? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FMED shares currently have a short interest ratio of 1.0. Learn More on Fidelity Disruptive Medicine ETF's short interest ratio. Is Fidelity Disruptive Medicine ETF's short interest increasing or decreasing? Fidelity Disruptive Medicine ETF saw a decline in short interest in the month of August. As of August 15th, there was short interest totaling 7,600 shares, a decline of 33.3% from the previous total of 11,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Fidelity Disruptive Medicine ETF's short interest compare to its competitors? Here is how the short interest of companies compare to Fidelity Disruptive Medicine ETF: Tradr 2X Long Innovation ETF (8.38%), Spear Alpha ETF (0.17%), Global X E-Commerce ETF (0.02%), Tema Oncology ETF (0.20%), Invesco ESG NASDAQ 100 ETF (0.54%), Fidelity Disruptive Communications ETF (1.49%), Global X Data Center & Digital Infrastructure ETF (21.51%), Roundhill GLP-1 & Weight Loss ETF (3.71%), Siren Nasdaq NexGen Economy ETF (0.32%), Global X Aging Population ETF (0.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.23 billion), Aptiv PLC ($2.50 billion), Royal Caribbean Cruises Ltd. ($2.48 billion), Paychex, Inc. ($2.25 billion), Moderna, Inc. ($2.17 billion), Cencora, Inc. ($2.12 billion), Tractor Supply ($1.93 billion), Onsemi ($1.82 billion), International Paper ($1.81 billion), and Rivian Automotive, Inc. ($1.72 billion). View all of the most shorted stocks. What does it mean to sell short Fidelity Disruptive Medicine ETF stock? Short selling FMED is an investing strategy that aims to generate trading profit from Fidelity Disruptive Medicine ETF as its price is falling. FMED shares are trading down $0.28 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Fidelity Disruptive Medicine ETF? A short squeeze for Fidelity Disruptive Medicine ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FMED, which in turn drives the price of the stock up even further. How often is Fidelity Disruptive Medicine ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FMED, twice per month. The most recent reporting period available is August, 15 2024. More Short Interest Resources from MarketBeat Related Companies: TARK Short Interest SPRX Short Interest EBIZ Short Interest CANC Short Interest QQMG Short Interest FDCF Short Interest VPN Short Interest OZEM Short Interest BLCN Short Interest AGNG Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FMED) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fidelity Disruptive Medicine ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Fidelity Disruptive Medicine ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.